UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Nuclear hkii–p-p53 (Ser15) interaction is a prognostic biomarker for chemoresponsiveness and glycolytic regulation in epithelial ovarian cancer Journal article
Han, Chae Young, Patten, David A., Kim, Se Ik, Lim, Jung Jin, Chan, David W., Siu, Michelle K.Y., Han, Youngjin, Carmona, Euridice, Parks, Robin J., Lee, Cheol, Di, Li Jun, Lu, Zhen, Chan, Karen K.L., Ku, Ja Lok, Macdonald, Elizabeth A., Vanderhyden, Barbara C., Mes-Masson, Anne Marie, Ngan, Hextan Y.S., Cheung, Annie N.Y., Song, Yong Sang, Bast, Robert C., Harper, Mary Ellen, Tsang, Benjamin K.. Nuclear hkii–p-p53 (Ser15) interaction is a prognostic biomarker for chemoresponsiveness and glycolytic regulation in epithelial ovarian cancer[J]. Cancers, 2021, 13(14), 3399.
Authors:  Han, Chae Young;  Patten, David A.;  Kim, Se Ik;  Lim, Jung Jin;  Chan, David W.; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.5/4.9 | Submit date:2021/12/08
Cancer Metabolism  Chemoresistance  Epithelial Ovarian Cancer  Hexokinase Ii  P-p53 (Ser15)  
Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP Journal article
Yi Liu-Chittenden, Bo Huang, Joong Sup Shim, Qian Chen, Se-Jin Lee, Robert A. Anders, Jun O. Liu, Duojia Pan. Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP[J]. GENES & DEVELOPMENT, 2012, 26(12), 1300-1305.
Authors:  Yi Liu-Chittenden;  Bo Huang;  Joong Sup Shim;  Qian Chen;  Se-Jin Lee; et al.
Favorite | TC[WOS]:1103 TC[Scopus]:1138  IF:7.5/10.5 | Submit date:2019/01/24
Hippo Signaling  Yap  Chemical Biology  Oncogene